Ex vivo cytokine production by whole mid-trimester amniotic fluid

Devrim Sezen1, Ann Marie Bongiovanni, Claudel Jean-Pierre

  • 1Division of Immunology & Infectious Diseases, Department of Obstetrics and Gynecology, Weill Medical College of Cornell University, New York, NY 10021, USA.

Insights

Ex vivo amniotic fluid culture reveals distinct immune mediator profiles compared to unincubated samples. This method may offer a more accurate prediction of spontaneous preterm birth (SPTB) risk.

Area of Science:

  • Reproductive immunology
  • Perinatal medicine
  • Biochemistry

Background:

  • Amniotic fluid immune mediators play a role in pregnancy outcomes.
  • Assessing intraamniotic immune mediator production ex vivo may differ from static measurements.

Purpose of the Study:

  • To investigate differences in immune mediator profiles between ex vivo cultured amniotic fluid and unincubated samples.
  • To determine if ex vivo immune mediator production can predict spontaneous preterm birth (SPTB).

Main Methods:

  • Amniotic fluid from 72 women was incubated ex vivo with or without lipopolysaccharide (LPS).
  • Levels of interleukin-6 (IL-6), IL-1 receptor antagonist (IL-1ra), IL-10, and nitric oxide were measured.
  • Comparison of mediator levels in cultured supernatants versus unincubated fluids and correlation with birth outcomes.

Main Results:

  • Ex vivo culture increased IL-6, IL-10, and nitric oxide release, while decreasing IL-1ra.
  • Women with SPTB showed decreased ex vivo IL-6 and increased IL-10 production compared to term delivery.
  • Unincubated fluids showed elevated IL-1ra in women with SPTB, an association not seen with ex vivo culture.

Conclusions:

  • Ex vivo amniotic fluid culture yields different immune mediator profiles than unincubated samples.
  • Ex vivo immune mediator production may be a more sensitive indicator of the intraamniotic environment's immune potential.
  • This approach may improve prediction of spontaneous preterm birth.